128 related articles for article (PubMed ID: 34022680)
1. Mutant CDKN2A regulates P16/p14 expression by alternative splicing in renal cell carcinoma metastasis.
Sun Q; Chen S; Hou Y; Wen X; Teng X; Zhang H; Lai C; Lai M
Pathol Res Pract; 2021 Jul; 223():153453. PubMed ID: 34022680
[TBL] [Abstract][Full Text] [Related]
2. Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma.
Song J; Liu YD; Su J; Yuan D; Sun F; Zhu J
J Cell Physiol; 2019 Dec; 234(12):22753-22764. PubMed ID: 31140607
[TBL] [Abstract][Full Text] [Related]
3. p14 expression differences in ovarian benign, borderline and malignant epithelial tumors.
Cabral VD; Cerski MR; Sa Brito IT; Kliemann LM
J Ovarian Res; 2016 Oct; 9(1):69. PubMed ID: 27770808
[TBL] [Abstract][Full Text] [Related]
4. CDKNA2A mutation analysis, protein expression, and deletion mapping of chromosome 9p in conventional clear-cell renal carcinomas: evidence for a second tumor suppressor gene proximal to CDKN2A.
Schraml P; Struckmann K; Bednar R; Fu W; Gasser T; Wilber K; Kononen J; Sauter G; Mihatsch MJ; Moch H
Am J Pathol; 2001 Feb; 158(2):593-601. PubMed ID: 11159196
[TBL] [Abstract][Full Text] [Related]
5. Single-cell analysis reveals metastatic cell heterogeneity in clear cell renal cell carcinoma.
Liu K; Gao R; Wu H; Wang Z; Han G
J Cell Mol Med; 2021 May; 25(9):4260-4274. PubMed ID: 33759378
[TBL] [Abstract][Full Text] [Related]
6. Systematic analysis of survival-associated alternative splicing signatures in clear cell renal cell carcinoma.
Chen T; Zheng W; Chen J; Lin S; Zou Z; Li X; Tan Z
J Cell Biochem; 2020 Oct; 121(10):4074-4084. PubMed ID: 31886566
[TBL] [Abstract][Full Text] [Related]
7. CDKN2A germline splicing mutation affecting both p16(ink4) and p14(arf) RNA processing in a melanoma/neurofibroma kindred.
Petronzelli F; Sollima D; Coppola G; Martini-Neri ME; Neri G; Genuardi M
Genes Chromosomes Cancer; 2001 Aug; 31(4):398-401. PubMed ID: 11433531
[TBL] [Abstract][Full Text] [Related]
8. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2.
Stott FJ; Bates S; James MC; McConnell BB; Starborg M; Brookes S; Palmero I; Ryan K; Hara E; Vousden KH; Peters G
EMBO J; 1998 Sep; 17(17):5001-14. PubMed ID: 9724636
[TBL] [Abstract][Full Text] [Related]
9. Genetic status of cell cycle regulators in squamous cell carcinoma of the oesophagus: the CDKN2A (p16(INK4a) and p14(ARF) ) and p53 genes are major targets for inactivation.
Smeds J; Berggren P; Ma X; Xu Z; Hemminki K; Kumar R
Carcinogenesis; 2002 Apr; 23(4):645-55. PubMed ID: 11960918
[TBL] [Abstract][Full Text] [Related]
10. Microsatellite alteration and immunohistochemical expression profile of chromosome 9p21 in patients with sporadic renal cell carcinoma following surgical resection.
El-Mokadem I; Lim A; Kidd T; Garret K; Pratt N; Batty D; Fleming S; Nabi G
BMC Cancer; 2016 Jul; 16():546. PubMed ID: 27465101
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
Clifford SC; Prowse AH; Affara NA; Buys CH; Maher ER
Genes Chromosomes Cancer; 1998 Jul; 22(3):200-9. PubMed ID: 9624531
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive analyses of cuproptosis-related gene CDKN2A on prognosis and immunologic therapy in human tumors.
Zhang D; Wang T; Zhou Y; Zhang X
Medicine (Baltimore); 2023 Apr; 102(14):e33468. PubMed ID: 37026918
[TBL] [Abstract][Full Text] [Related]
13. Aberrations of the p14(ARF) and p16(INK4a) genes in renal cell carcinomas.
Kawada Y; Nakamura M; Ishida E; Shimada K; Oosterwijk E; Uemura H; Hirao Y; Chul KS; Konishi N
Jpn J Cancer Res; 2001 Dec; 92(12):1293-9. PubMed ID: 11749694
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis on the expression levels and prognostic values of LOX family genes in kidney renal clear cell carcinoma.
Lin S; Zheng L; Lu Y; Xia Q; Zhou P; Liu Z
Cancer Med; 2020 Nov; 9(22):8624-8638. PubMed ID: 32970930
[TBL] [Abstract][Full Text] [Related]
15. Expression and significance of histone H3K27 demethylases in renal cell carcinoma.
Shen Y; Guo X; Wang Y; Qiu W; Chang Y; Zhang A; Duan X
BMC Cancer; 2012 Oct; 12():470. PubMed ID: 23057811
[TBL] [Abstract][Full Text] [Related]
16. [The molecular pathogenesis and prognosis of renal cell carcinoma].
Serth J
Urologe A; 2007 Sep; 46(9):1168-9. PubMed ID: 17668170
[No Abstract] [Full Text] [Related]
17. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.
Boström J; Meyer-Puttlitz B; Wolter M; Blaschke B; Weber RG; Lichter P; Ichimura K; Collins VP; Reifenberger G
Am J Pathol; 2001 Aug; 159(2):661-9. PubMed ID: 11485924
[TBL] [Abstract][Full Text] [Related]
18. Frequent deletion and methylation in SH3GL2 and CDKN2A loci are associated with early- and late-onset breast carcinoma.
Sinha S; Chunder N; Mukherjee N; Alam N; Roy A; Roychoudhury S; Kumar Panda C
Ann Surg Oncol; 2008 Apr; 15(4):1070-80. PubMed ID: 18239974
[TBL] [Abstract][Full Text] [Related]
19. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA
Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779
[TBL] [Abstract][Full Text] [Related]
20. Prognostic role of E2F1 and members of the CDKN2A network in gastrointestinal stromal tumors.
Haller F; Gunawan B; von Heydebreck A; Schwager S; Schulten HJ; Wolf-Salgó J; Langer C; Ramadori G; Sültmann H; Füzesi L
Clin Cancer Res; 2005 Sep; 11(18):6589-97. PubMed ID: 16166437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]